Early Diagnosis of Leukemic Children Patients Based on Clinical, Age Estimation and Radiographical Evaluation of Oral Affection
NCT ID: NCT04756258
Last Updated: 2021-02-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
10 participants
OBSERVATIONAL
2020-01-30
2020-10-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
"Peripheral Blood Dipeptidylpeptidase IV (CD26) Positive Leukemic Stem Cells in Chronic Myeloid Leukemia as a Diagnostic Marker"
NCT05543161
Expression of Programmed Death-1 (PD-1) & Programmed Death Ligand-1 (PDL-1) in Acute Lymphoblastic Leukemia in Pediatric
NCT05428111
Biomarkers in Young Patients With Acute Myeloid Leukemia
NCT01138332
Assessing the Ontogeny of P-glycoprotein Expression in Blood of Pediatric Leukemic Patients
NCT05021159
Low Dose Daunorubicin in Pediatric Relapsed/Refractory Acute Leukemia
NCT04562792
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
\-
Exclusion Criteria
2. Children already diagnosed by leukemia and started treatment
3. Children diagnosed by other bone lesions showing osteolytic bone or anemia as thalassemia or sickle cell anemia or any other bone pathology
6 Years
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
rehab ghouraba
lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
rehab f ghouraba, PHD
Role: PRINCIPAL_INVESTIGATOR
Tanta university, faculty of dentistry, Oral medicine clinic
rehab f ghouraba
Role: PRINCIPAL_INVESTIGATOR
Tanta university, faculty of dentistry, Oral medicine clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rehab Fouad Ghouraba
Tanta, Grabia, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
222
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.